Dignitana’s business concept is to develop, manufacture and market a medical device primarily used for scalp cooling, to eliminate or greatly reduce chemotherapy induced hair loss.
The company focuses on the patented product DigniCap™, which counteracts hair loss during chemotherapy. The product has been used by thousands of patients, and during 2009 the company launched a new generation of the system on the international market.
Patents and trade marks
The company’s DigniCap™ system is patented in Europe, Japan and the USA. Moreover, a number of new patent applications were submitted in 2008 for further developments of the system. A new generation of the DigniCap™ system was delivered to the first customers in the summer of 2009.
Dignitana is certified under ISO 13 485 and the company’s products are CE certified as class II a.